Breast Cancer: The Prognostic Value of Tumor-Infiltrating Lymphocytes
At the 2024 San Antonio Breast Cancer Symposium, Dr. and PhD student Demet Özcan presented a study from the Danish Breast Cancer Study. In this MEDtalk, she presents the study that confirms the prognostic value of tumor-infiltrating lymphocytes (TILs) in breast cancer patients undergoing radiotherapy, validating earlier findings with modern treatment standards.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in